Company intelligence / Profile preview

MOA Life Plus Co. Ltd.

Yongin-si, Gyeonggi-do, South Koreamoalifeplus.com ↗

Ownership: Public · A142760
Employees: ~51
Development stage: Phase 2

Overview

MOA Life Plus Co. Ltd., formerly known as Bioleaders Corporation and BL Corp, is a South Korean biotechnology and biopharmaceutical company focused on developing therapeutics for oncology and rare diseases. Its lead asset for cervical cancer has reached late-stage clinical trials. The company also develops health functional foods and cosmetics alongside its pharmaceutical R&D activities.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Therapeutic vaccinesProbioticsSmall molecule drugsProphylactic vaccinesTargeted anti-cancer drugs
Industry: Biotech

Drug pipeline

9 assets

Poly-gamma-glutamic acid

8 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on MOA Life Plus Co. Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MOA Life Plus Co. Ltd..

Explore the full profile